180 related articles for article (PubMed ID: 24779032)
1. Ambulatory quality indicators to prevent infection in sickle cell disease.
Beverung LM; Brousseau D; Hoffmann RG; Yan K; Panepinto JA
Am J Hematol; 2014 Mar; 89(3):256-60. PubMed ID: 24779032
[TBL] [Abstract][Full Text] [Related]
2. Adherence to Quality of Care Indicators and Location of Sickle Cell Care Within Indiana.
Meier ER; Janson IA; Hampton K; Bloom E; Duncan N; Roberson C; Rampersad A
J Community Health; 2020 Feb; 45(1):81-87. PubMed ID: 31396825
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal vaccination rates in children with sickle cell disease.
Nero AC; Akuete K; Leasure Reeves S; Dombkowski KJ
J Public Health Manag Pract; 2014; 20(6):587-90. PubMed ID: 24253403
[TBL] [Abstract][Full Text] [Related]
4. Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease.
Sox CM; Cooper WO; Koepsell TD; DiGiuseppe DL; Christakis DA
JAMA; 2003 Aug; 290(8):1057-61. PubMed ID: 12941678
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
Rankine-Mullings AE; Owusu-Ofori S
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003427. PubMed ID: 28994899
[TBL] [Abstract][Full Text] [Related]
6. Adherence to prophylactic antibiotic guidelines among Medicaid infants with sickle cell disease.
Warren MD; Arbogast PG; Dudley JA; Kaltenbach L; Ray WA; Wang WC; Cooper WO
Arch Pediatr Adolesc Med; 2010 Mar; 164(3):298-9. PubMed ID: 20194269
[No Abstract] [Full Text] [Related]
7. Streptococcus pneumoniae sepsis and meningitis during the penicillin prophylaxis era in children with sickle cell disease.
Hord J; Byrd R; Stowe L; Windsor B; Smith-Whitley K
J Pediatr Hematol Oncol; 2002; 24(6):470-2. PubMed ID: 12218595
[TBL] [Abstract][Full Text] [Related]
8. Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009-2015.
Payne AB; Adamkiewicz TV; Grosse SD; Steffens A; Shay DK; Reed C; Schieve LA
Pediatr Blood Cancer; 2021 Dec; 68(12):e29351. PubMed ID: 34542932
[TBL] [Abstract][Full Text] [Related]
9. Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.
Chen CJ; Bakeera-Kitaka S; Mupere E; Kasirye P; Munube D; Idro R; Hume H; Pfeffer B; LaRussa P; Green NS
J Paediatr Child Health; 2019 Jul; 55(7):795-801. PubMed ID: 30411430
[TBL] [Abstract][Full Text] [Related]
10. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
[TBL] [Abstract][Full Text] [Related]
11. Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature.
Oligbu G; Fallaha M; Pay L; Ladhani S
Br J Haematol; 2019 May; 185(4):743-751. PubMed ID: 30859558
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis of pneumococcal infection in sickle-cell disease by the combined use of vaccination and penicillin.
Babiker MA
Ann Trop Paediatr; 1986 Sep; 6(3):179-81. PubMed ID: 2430506
[TBL] [Abstract][Full Text] [Related]
13. Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.
Vekeman F; Sasane M; Cheng WY; Ramanakumar AV; Fortier J; Qiu Y; Duh MS; Paley C; Adams-Graves P
J Med Econ; 2016; 19(3):292-303. PubMed ID: 26618853
[TBL] [Abstract][Full Text] [Related]
14. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
15. American Academy of Pediatrics. Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.
Pediatrics; 2000 Aug; 106(2 Pt 1):362-6. PubMed ID: 10920169
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
Hirst C; Owusu-Ofori S
Cochrane Database Syst Rev; 2014 Nov; (11):CD003427. PubMed ID: 25375222
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.
Hirst C; Owusu-Ofori S
Cochrane Database Syst Rev; 2012 Sep; (9):CD003427. PubMed ID: 22972063
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia.
Buchanan GR; Smith SJ
Am J Dis Child; 1986 May; 140(5):428-32. PubMed ID: 3962935
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease.
Candrilli SD; O'Brien SH; Ware RE; Nahata MC; Seiber EE; Balkrishnan R
Am J Hematol; 2011 Mar; 86(3):273-7. PubMed ID: 21328441
[TBL] [Abstract][Full Text] [Related]
20. Parental health beliefs and compliance with prophylactic penicillin administration in children with sickle cell disease.
Elliott V; Morgan S; Day S; Mollerup LS; Wang W
J Pediatr Hematol Oncol; 2001 Feb; 23(2):112-6. PubMed ID: 11216702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
